A double-blind, placebo-controlled, glutamine-supplementation trial in growth-faltering Gambian infants | Zendy

Elizabeth A. Williams | Zendy; Marinos Elia | Zendy; P. G. Lunn | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A double-blind, placebo-controlled, glutamine-supplementation trial in growth-faltering Gambian infants

Author(s) -

Elizabeth A. Williams,

Marinos Elia,

P. G. Lunn

Publication year - 2007

Publication title -

american journal of clinical nutrition

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.608

H-Index - 336

eISSN - 1938-3207

pISSN - 0002-9165

DOI - 10.1093/ajcn/86.2.421

Subject(s) - lactulose , glutamine , intestinal permeability , placebo , medicine , gastroenterology , enteropathy , endocrinology , immunology , biology , amino acid , biochemistry , alternative medicine , disease , pathology

Growth faltering during infancy is a characteristic of life in developing countries. Previous studies have shown that small-intestine mucosal enteropathy, accompanied by endotoxemia and a persistent systemic inflammatory response, accounts for up to 64% of the growth faltering in Gambian infants.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research